Purpose: Although matched-sibling donor (MSD) hematopoietic stem-cell transplantation
(HSCT) has an established role in the management of adults with acute lymphoblastic …

Background The use of post-transplant cyclophosphamide (PTCy) is highly effective in
preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting …

We conducted a prospective, multicentre study to confirm the feasibility of haplo‐identical
transplantation in treatment of severe aplastic anaemia (SAA) as salvage therapy, by …

Background Acute graft-versus-host disease (aGVHD) remains the major cause of early
mortality after haploidentical related donor (HID) hematopoietic stem cell transplantation …

Severe graft-versus-host disease is a major barrier for non-T-cell-depleted haploidentical
stem cell transplantation. There is no consensus on the optimal graft-versus-host disease …

Allogeneic hematopoietic stem cell transplantation is the optimal care for patients with high-
risk or intermediate-acute myeloid leukemia. In patients lacking matched sibling donor …

The role of allogeneic hematopoietic stem cell transplantation (HCT) in the treatment of
acute myelogenous leukemia (AML) in children is reviewed and critically evaluated in this …

Allogeneic stem cell transplantation (allo-SCT) is a curable method for the treatment of
hematological malignancies. In the past two decades, the establishment of haploidentical …

Encouraging results from a small sample of patients with myelodysplastic syndrome (MDS)
undergoing haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) must …

Allogeneic blood or marrow hematopoietic cell transplantation continues to be the most
potent anti-leukemic treatment for adult patients with standard, high-risk, or chemo-refractory …